The Michael J. Fox Foundation for Parkinson’s Research has partnered with Grifols, a global healthcare company, to identify ...
A 47-year-old man was the first in the world to be treated outside of a study context with a new technique for the symptoms ...
The US company has said it is launching the Phase III trials in the first half of this year after Phase I talks with the US ...
Delray Medical Center cut the ribbon on its newest high-tech machine that targets brain areas to treat movement disorders ...
A new study has identified a potential link between hearing impairment and an increased risk of developing Parkinson’s ...
In the past, Parkinson’s disease was primarily considered a disorder of the nervous system, centered in the brain. However, ...
Bemdaneprocel will be studied in a sham-surgery controlled, double-blind trial that is expected to start in the first half of ...